GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (NYSE:TAK) » Definitions » Dividend-Payout-to-FFO

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Dividend-Payout-to-FFO


View and export this data going back to 2010. Start your Free Trial

What is Takeda Pharmaceutical Co Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Business Description

Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.